Molecular characterization of carbapenem-resistant Pseudomonas aeruginosa strains isolated from patients with urinary tract infections in Southern Poland

Diagnostic Microbiology and Infectious Disease

Volumn 83, Issue 3, 2015, Pages 295-297

  Pobiega, Monika ^a   Maciag, Joanna ^a   Chmielarczyk, Agnieszka ^a   Romaniszyn, Dorota ^a   Pomorska Wesolowska, Monika ^b   Ziolkowski, Grzegorz ^c   Heczko, Piotr B ^a   Bulanda, Malgorzata ^a   Wojkowska Mach, Jadwiga ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^c Higher School of Medicine in Sosnowiec   (Poland)

Author keywords

Carbapenem resistance; Exo; MLST; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DORIPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TOBRAMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CARBAPENEM RESISTANT PSEUDOMONAS AERUGINOSA; CHILD; EXOS GENE; EXOT GENE; EXOU GENE; EXOY GENE; EXTENSIVELY DRUG RESISTANT PSEUDOMONAS AERUGINOSA; FEMALE; HUMAN; MALE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLAND; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; URINALYSIS; URINARY TRACT INFECTION; VERY ELDERLY; ANTIBIOTIC RESISTANCE; CLASSIFICATION; CLUSTER ANALYSIS; DRUG EFFECTS; GENETIC VARIATION; GENETICS; GENOTYPE; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PSEUDOMONAS INFECTIONS; SECRETION (PROCESS); URINARY TRACT INFECTIONS;

ADOLESCENT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CLUSTER ANALYSIS; FEMALE; GENES, BACTERIAL; GENETIC VARIATION; GENOTYPE; HUMANS; INFANT; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; POLAND; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; URINARY TRACT INFECTIONS;

EID: 84943588039     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.07.022     Document Type: Article

References (22)

1. Ajayi T., Allmond L.R., Sawa T., Wiener-Kronish J.P. Single-nucleotide-polymorphism mapping of the Pseudomonas aeruginosa type III secretion toxins for development of a diagnostic multiplex PCR system. J Clin Microbiol 2003, 41(8):3526-3531.
2. Curran B., Jonas D., Grundmann H., Pitt T., Dowson C.G. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 2004, 42(12):5644-5649.
3. Cuzon G., Naas T., Villegas M.V., Correa A., Quinn J.P., Nordmann P. Wide dissemination of Pseudomonas aeruginosa producing beta-lactamase blaKPC-2 gene in Colombia. Antimicrob Agents Chemother 2011, 55(11):5350-5353.
4. Empel J., Filczak K., Mrowka A., Hryniewicz W., Livermore D.M., Gniadkowski M. Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex. J Clin Microbiol 2007, 45(9):2829-2834.
5. Ferreira M.L., Dantas R.C., Faria A.L., Goncalves I.R., Silveira de Brito C., Queiroz L.L., Gontijo-Filho P.P., Ribas R.M. Molecular epidemiological survey of the quinolone- and carbapenem-resistant genotype and its association with the type III secretion system in Pseudomonas aeruginosa. J Med Microbiol 2015, 64(Pt 3):262-271.
6. Franco M.R., Caiaffa-Filho H.H., Burattini M.N., Rossi F. Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital. Clinics (Sao Paulo) 2010, 65(9):825-829.
7. Hamood A.N., Griswold J.A., Duhan C.M. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections. J Surg Res 1996, 61(2):425-432.
8. Hryniewicz K., Szczypa K., Sulikowska A., Jankowski K., Betlejewska K., Hryniewicz W. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother 2001, 47(6):773-780.
9. Knight D.A., Finck-Barbancon V., Kulich S.M., Barbieri J.T. Functional domains of Pseudomonas aeruginosa exoenzyme S. Infect Immun 1995, 63(8):3182-3186.
10. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18(3):268-281.
11. Narten M., Rosin N., Schobert M., Tielen P. Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance. Curr Microbiol 2012, 64(1):7-16.
12. Obritsch M.D., Fish D.N., MacLaren R., Jung R. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother 2004, 48(12):4606-4610.
13. Obritsch M.D., Fish D.N., MacLaren R., Jung R. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 2005, 25(10):1353-1364.
14. Pena C., Cabot G., Gomez-Zorrilla S., Zamorano L., Ocampo-Sosa A., Murillas J., et al. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections. Clin Infect Dis 2015, 60(4):539-548.
15. Pobiega M., Wojkowska-Mach J., Maciag J., Chmielarczyk A., Romaniszyn D., Pomorska-Wesolowska M., et al. Virulence and antibiotic resistance of Pseudomonas aeruginosa isolated from patients with urinary tract infections in Southern Poland. Chemotherapy 2015, 60(4):253-260.
16. Rossolini G.M. Acquired metallo-beta-lactamases: an increasing clinical threat. Clin Infect Dis 2005, 41(11):1557-1558.
17. Roy-Burman A., Savel R.H., Racine S., Swanson B.L., Revadigar N.S., Fujimoto J., et al. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis 2001, 183(12):1767-1774.
18. Sullivan E., Bensman J., Lou M., Agnello M., Shriner K., Wong-Beringer A. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa. Crit Care Med 2014, 42(1):48-56.
19. Vance R.E., Rietsch A., Mekalanos J.J. Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect Immun 2005, 73(3):1706-1713.
20. Viedma E., Juan C., Acosta J., Zamorano L., Otero J.R., Sanz F., et al. Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain. Antimicrob Agents Chemother 2009, 53(11):4930-4933.
21. Yakupogullari Y., Poirel L., Bernabeu S., Kizirgil A., Nordmann P. Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum beta-lactamase PER-1 and metallo-beta-lactamase VIM-2 from Turkey. J Antimicrob Chemother 2008, 61(1):221-222.
22. Yoon B.I., Kim H.S., Kim S.D., Cho K.J., Kim S.W., Ha U.S., et al. Changes in bacterial species and antibiotic sensitivity in intensive care unit: acquired urinary tract infection during 10years interval (2001-2011). Urol J 2014, 11(2):1478-1484.